These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 39121514)

  • 1. Takotsubo syndrome is triggered by hypoactive delirium and recognized by increased catecholamine requirement in the ICU.
    Scorza CA; Finsterer J; Scorza FA
    Clinics (Sao Paulo); 2024; 79():100466. PubMed ID: 39121514
    [No Abstract]   [Full Text] [Related]  

  • 2. Takotsubo syndrome triggered by acute intermittent porphyria attack: An unusual stressor for catecholamine-induced cardiomyopathy.
    Messas N; Willemain R; Bilger A; Rondeau-Lutz M; Kuhnert C; Mertes PM; Morel O; Collange O
    Int J Cardiol; 2016 Mar; 207():28-30. PubMed ID: 26788817
    [No Abstract]   [Full Text] [Related]  

  • 3. Current hypotheses regarding the pathophysiology behind the takotsubo syndrome.
    Redfors B; Shao Y; Ali A; Omerovic E
    Int J Cardiol; 2014 Dec; 177(3):771-9. PubMed ID: 25466564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma catecholamine levels in patients with takotsubo syndrome: Implications for the pathogenesis of the disease.
    Y-Hassan S; Henareh L
    Int J Cardiol; 2015 Feb; 181():35-8. PubMed ID: 25481310
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical outcomes associated with catecholamine use in patients diagnosed with Takotsubo cardiomyopathy.
    Ansari U; El-Battrawy I; Fastner C; Behnes M; Sattler K; Huseynov A; Baumann S; Tülümen E; Borggrefe M; Akin I
    BMC Cardiovasc Disord; 2018 Mar; 18(1):54. PubMed ID: 29554866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features, complications, and outcomes of exogenous and endogenous catecholamine-triggered Takotsubo syndrome: A systematic review and meta-analysis of 156 published cases.
    Y-Hassan S; Falhammar H
    Clin Cardiol; 2020 May; 43(5):459-467. PubMed ID: 32125009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-Induced Takotsubo Cardiomyopathy.
    Kido K; Guglin M
    J Cardiovasc Pharmacol Ther; 2017 Nov; 22(6):552-563. PubMed ID: 28490198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stress cardiomyopathies beyond Takotsubo: does a common catecholaminergic pathophysiology fit all?
    Andò G; Boretti I; Tripodi R
    Expert Rev Cardiovasc Ther; 2014 Jun; 12(6):643-5. PubMed ID: 24716866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated left ventricular basal ballooning in young women: "inverted takotsubo" pattern related to catecholamine-toxicity.
    Sanchez-Recalde A; Iborra C; Costero O; Moreno R; López de Sá E; Sobrino JA; López-Sendón JL
    Am J Cardiol; 2007 Nov; 100(9):1496-7. PubMed ID: 17950820
    [No Abstract]   [Full Text] [Related]  

  • 10. Takotsubo cardiomyopathy systematic review: Pathophysiologic process, clinical presentation and diagnostic approach to Takotsubo cardiomyopathy.
    Ono R; Falcão LM
    Int J Cardiol; 2016 Apr; 209():196-205. PubMed ID: 26896623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Takotsubo syndrome.
    Balkin DM; Cohen LS
    Coron Artery Dis; 2011 May; 22(3):206-14. PubMed ID: 21183854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A tale of a cobra and an octopus: Takotsubo cardiomyopathy following a snake bite.
    Van Rensburg A; Kyriakakis C
    Am J Med; 2015 Apr; 128(4):e5-6. PubMed ID: 25460533
    [No Abstract]   [Full Text] [Related]  

  • 13. Deleterious effects of catecholamine administration in acute heart failure caused by unrecognized Takotsubo cardiomyopathy.
    Dandel M; Hetzer R
    BMC Cardiovasc Disord; 2018 Jul; 18(1):144. PubMed ID: 29996761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential drugs for the management of patients with takotsubo syndrome.
    Madias JE
    Int J Cardiol; 2016 Oct; 221():12-3. PubMed ID: 27395819
    [No Abstract]   [Full Text] [Related]  

  • 15. Association of Hypoactive and Hyperactive Delirium With Cognitive Function After Critical Illness.
    Hayhurst CJ; Marra A; Han JH; Patel MB; Brummel NE; Thompson JL; Jackson JC; Chandrasekhar R; Ely EW; Pandharipande PP; Hughes CG
    Crit Care Med; 2020 Jun; 48(6):e480-e488. PubMed ID: 32317589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Sympathetic Nervous System in the Pathogenesis of Takotsubo Syndrome.
    Wittstein IS
    Heart Fail Clin; 2016 Oct; 12(4):485-98. PubMed ID: 27638019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and Prevalence of Delirium Subtypes in an Adult ICU: A Systematic Review and Meta-Analysis.
    Krewulak KD; Stelfox HT; Leigh JP; Ely EW; Fiest KM
    Crit Care Med; 2018 Dec; 46(12):2029-2035. PubMed ID: 30234569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress (Tako-tsubo) cardiomyopathy in critically-ill patients.
    Champion S; Belcour D; Vandroux D; Drouet D; Gaüzère BA; Bouchet B; Bossard G; Djouhri S; Jabot J; Champion M; Lefort Y
    Eur Heart J Acute Cardiovasc Care; 2015 Apr; 4(2):189-96. PubMed ID: 25202025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incremental "Therapeutic" Myocardial Exposure to Catecholamines: Incidence and Impact in Takotsubo Syndrome.
    Ong GJ; Nguyen TH; Stansborough J; Surikow SY; Horowitz JD
    Cardiovasc Drugs Ther; 2020 Feb; 34(1):95-100. PubMed ID: 32076930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the pathophysiology of takotsubo syndrome triggered by administered adrenergic agonists, noted in the JADER database.
    Madias JE
    J Cardiol; 2022 Apr; 79(4):564-565. PubMed ID: 34836724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.